Last update 04 Nov 2024
Sodium Monosialotetrahexosylganglioside
Last update 04 Nov 2024
Overview
Basic Info
Drug Type Chemical drugs |
Synonyms 申捷 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC73H131N3NaO31 |
InChIKeySCNDOMAFNZIBOJ-POYTVKKJSA-N |
CAS Registry1694670-82-0 |
Related
6
Clinical Trials associated with Sodium Monosialotetrahexosylganglioside评价单唾液酸四己糖神经节苷脂钠注射液（GM1）预防注射用紫杉醇（白蛋白结合型）方案辅助/新辅助治疗乳腺癌患者所致周围神经病变的多中心、随机、双盲II期临床研究
[Translation] A multicenter, randomized, double-blind phase II clinical study to evaluate the effect of monosialotetrahexosylganglioside sodium injection (GM1) in preventing peripheral neuropathy caused by adjuvant/neoadjuvant treatment of breast cancer patients with paclitaxel (albumin-bound) injection
急性缺血性脑卒中患者的确证性临床研究
[Translation] Confirmatory clinical study in patients with acute ischemic stroke
单唾液酸四己糖神经节苷脂钠注射液(GM1)治疗急性缺血性脑卒中的有效性及安全性的随机、双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the efficacy and safety of monosialotetrahexosylganglioside sodium injection (GM1) in the treatment of acute ischemic stroke
100 Clinical Results associated with Sodium Monosialotetrahexosylganglioside
Login to view more data
100 Translational Medicine associated with Sodium Monosialotetrahexosylganglioside
Login to view more data
100 Patents (Medical) associated with Sodium Monosialotetrahexosylganglioside
Login to view more data
100 Deals associated with Sodium Monosialotetrahexosylganglioside
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Craniocerebral Trauma | CN | - | - |
| Spinal Cord Injuries | CN | - | - |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Ischemic Stroke | Phase 3 | CN | 05 Dec 2019 | |
| Breast Cancer | Phase 2 | CN | 21 Jul 2023 | |
| Peripheral Nervous System Diseases | Phase 2 | CN | 21 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT02251977 (Pubmed) Manual  | Phase 3 | 196 | Monosialotetrahexosylganglioside (GM1) | omyvmttqob(rmbqchljdb) = kfxmyamdyv wqejdcivqo (qyyapmyjaq ) View more | Negative | 01 Jan 2020 | |
Placebo | omyvmttqob(rmbqchljdb) = fgddnkradr wqejdcivqo (qyyapmyjaq ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free